James I. Porter

Swedish Medical Center, Medtronic (Ireland)

Papers

4

Total Citations

58

H-Index

2

About

James I. Porter is a leading figure in urologic oncology and robotic-assisted surgery, whose work has fundamentally shaped how prostate cancer is treated surgically. His primary research areas include the implementation and outcomes of novel robotic platforms, such as the Hugo™ RAS system, and the refinement of surgical techniques like pelvic lymphadenectomy. Porter’s most impactful contribution is his pioneering study on the implementation and outcomes of the Hugo™ RAS System in robotic-assisted radical prostatectomy, which has garnered 40 citations and provides critical early evidence on the safety and efficacy of this emerging technology. He has also advanced surgical education through the development and validation of the End-to-End Assessment of Suturing Expertise (EASE), a tool that objectively measures surgical skill. More recently, Porter has been at the forefront of remote robotic-assisted surgery, proposing a framework that bridges innovation with patient safety—a work that promises to expand access to high-quality surgical care. With a career dedicated to both technical innovation and rigorous outcomes research, Porter’s contributions are essential reading for anyone interested in the future of minimally invasive surgery.

Research Focus

Key Achievements

2
H-Index
4
Papers
58
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Implementation and outcomes of HugoTM RAS System in robotic-assisted radical prostatectomy
40 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 41
🏛 Institutions: Swedish Medical Center, Medtronic (Ireland)

Top Papers

  1. 1
  2. 2
    Pelvic Lymphadenectomy
    14 citations · 2017
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago